DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sacheerome Limited — Investor Presentation

NSE 1d ago·2 Nov 2026, 1:08 pm

Sacheerome

Sacheerome Limited has announced that it will conduct an investor presentation. This event allows the company to directly communicate its business strategy, financial performance, and future outlook to the market. It is a standard procedure for listed firms to share detailed plans with shareholders and potential investors.

For investors, this update is significant as it provides clarity on the company's direction. It offers a chance to understand management's view on current market conditions and upcoming projects. This information helps investors assess the company's growth potential and operational health before making any decisions.

Investors should watch for details regarding the company's revenue projections, capital expenditure plans, and any updates on ongoing projects. Following the presentation, market sentiment and the stock's reaction to the information will be key indicators of how the market perceives Sacheerome's future prospects.